PTPN7 Antibody: Selection, Validation & Application Guide

PTPN7 Antibody is a research-grade immunoreagent designed to detect and study PTPN7, a non-receptor protein tyrosine phosphatase involved in the regulation of MAPK signaling pathways and immune cell function.

Product SKU

Ab349232

Target Protein

PTPN7 (Protein Tyrosine Phosphatase Non-Receptor Type 7)

Protein Family

Non-receptor class protein tyrosine phosphatases (PTPs)

Biological Function

Regulation of MAPK/ERK signaling; modulation of immune cell activation and differentiation

Primary Research Areas

Immunology, cell signaling, oncology, hematopoiesis

Recommended Storage

-20°C; avoid repeated freeze-thaw cycles

Target Overview: What Is PTPN7?

PTPN7, also known as HePTP (Hematopoietic Protein Tyrosine Phosphatase), is a member of the non-receptor protein tyrosine phosphatase (PTP) superfamily. It is predominantly expressed in hematopoietic tissues and plays a central role in regulating mitogen-activated protein kinase (MAPK) signaling cascades, including ERK1/2 and p38 MAPK pathways.

By dephosphorylating key tyrosine residues on ERK and p38, PTPN7 acts as a negative regulator of T-cell receptor (TCR) and cytokine-mediated signaling, influencing T-cell activation, differentiation, and immune tolerance. Its dysregulation has been associated with inflammatory disorders and certain hematological malignancies, making it a relevant target for both basic immunology research and translational studies.

Understanding PTPN7 expression levels and subcellular localization in normal versus diseased tissue requires reliable, well-validated antibody tools, underscoring the importance of using a high-quality reagent such as Ab349232 from Aladdin Scientific.

Antibody Selection Criteria for PTPN7 Detection

Selecting the right PTPN7 antibody requires careful consideration of several parameters to ensure specificity, sensitivity, and compatibility with your experimental system:

• Host Species and Clonality: Consider whether a monoclonal or polyclonal antibody best suits your application. Monoclonals offer high reproducibility and epitope specificity, while polyclonals may provide greater signal sensitivity across multiple epitopes.
• Target Epitope: Confirm whether the antibody recognizes a native or denatured epitope, as this directly affects compatibility with applications such as Western blot (WB), immunoprecipitation (IP), immunofluorescence (IF), and immunohistochemistry (IHC).
• Species Reactivity: Verify the antibody's validated reactivity against your model organism (e.g., human, mouse, rat) prior to purchase and use.
• Application Compatibility: Review the supplier's validated application data. Ab349232 should be assessed for its validated use cases before designing experiments.
• Lot-to-Lot Consistency: For longitudinal studies, prioritize suppliers with rigorous lot-release testing to minimize inter-experiment variability.

Always consult the product datasheet for Ab349232 on the Aladdin Scientific website for the most current specifications and validated applications.

Recommended Protocols and Best Practices

The following general protocol guidelines apply to common applications of PTPN7 Antibody (Ab349232). Always refer to the specific product datasheet for optimized conditions.

Western Blot (WB)

1. Prepare whole-cell lysates from PTPN7-expressing cell lines (e.g., hematopoietic or T-cell lines) using an appropriate lysis buffer supplemented with phosphatase and protease inhibitors.
2. Resolve 20–40 µg of total protein by SDS-PAGE and transfer to PVDF or nitrocellulose membrane.
3. Block membrane with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature.
4. Incubate with PTPN7 Antibody (Ab349232) at the recommended dilution (refer to datasheet) overnight at 4°C.
5. Wash with TBST (3×10 min) and incubate with appropriate HRP-conjugated secondary antibody for 1 hour at room temperature.
6. Detect signal using chemiluminescent substrate. Expected band: consult the datasheet for the reported molecular weight of PTPN7.

Immunofluorescence (IF) / Immunohistochemistry (IHC)

1. Fix cells or tissue sections using 4% paraformaldehyde; perform antigen retrieval for FFPE sections as appropriate.
2. Block with 5–10% normal serum matching the secondary antibody host species.
3. Apply PTPN7 Antibody at the recommended dilution; incubate overnight at 4°C in a humidified chamber.
4. Wash and apply fluorophore- or enzyme-conjugated secondary antibody; counterstain nuclei as required.
5. Image and analyze using appropriate microscopy or digital pathology platforms.

General Tips: Always include a no-primary-antibody negative control. Where possible, use PTPN7-knockout or knockdown cell lines as specificity controls.

Troubleshooting Common Issues

Even with optimized protocols, researchers may encounter technical challenges. The table below summarizes common issues and recommended corrective actions for PTPN7 Antibody experiments:

• No signal or weak signal: Verify that the target is expressed in your cell or tissue model. Check antibody dilution, incubation time, and secondary antibody compatibility. Ensure lysate preparation was performed with adequate inhibitors to prevent PTPN7 degradation.
• High background: Extend blocking time or increase wash stringency (number or duration of washes). Optimize primary antibody concentration by titration. Confirm secondary antibody does not cross-react with the blocking agent.
• Non-specific bands (WB): Run a parallel lane with a PTPN7-negative or knockdown lysate. Consult the datasheet for the expected molecular weight and confirm band identity. Consider switching to a more stringent lysis buffer.
• Inconsistent results between experiments: Standardize cell passage number, lysis conditions, and protein quantification method. Use the same antibody lot where possible. Store aliquots at -20°C and avoid freeze-thaw cycles.
• Weak IHC staining: Optimize antigen retrieval method (heat-induced vs. enzymatic). Adjust primary antibody concentration and incubation time. Confirm tissue fixation duration is within the recommended range.

Quality, Validation, and Responsible Use

Antibody validation is a cornerstone of reproducible research. Aladdin Scientific is committed to supplying research-grade reagents that meet rigorous quality standards. For PTPN7 Antibody (Ab349232), researchers should adopt the following validation framework:

• Genetic validation: Test the antibody in PTPN7-overexpressing and PTPN7-knockout or knockdown cell lines to confirm specificity of detection.
• Orthogonal validation: Corroborate antibody-based detection with an independent method, such as RT-qPCR for mRNA expression or mass spectrometry for protein identification.
• Independent antibody validation: Where feasible, use a second antibody targeting a different PTPN7 epitope to confirm signal specificity.
• Positive and negative controls: Always include well-characterized positive control lysates or tissues and no-primary-antibody negative controls in every experiment.

Proper documentation of antibody lot number, dilution, incubation conditions, and validation data is essential for publication-quality data and regulatory compliance. Researchers are encouraged to report antibody usage details following community guidelines (e.g., antibody RRID citation practices) to promote scientific reproducibility.

For ordering, technical support, or custom requirements related to Ab349232, please contact Aladdin Scientific's technical service team.

Frequently asked questions

What is PTPN7 and why is it an important research target?

PTPN7 (Hematopoietic Protein Tyrosine Phosphatase, HePTP) is a non-receptor PTP predominantly expressed in hematopoietic cells that negatively regulates MAPK/ERK and p38 signaling. Its role in T-cell activation, immune tolerance, and potential involvement in hematological malignancies makes it a significant target in immunology and oncology research.

Which applications is PTPN7 Antibody (Ab349232) suitable for?

Ab349232 is intended for research applications including Western blot (WB), immunofluorescence (IF), and immunohistochemistry (IHC), among others. Please consult the current product datasheet on the Aladdin Scientific website for the complete and up-to-date list of validated applications and recommended conditions, as specifications may be updated.

How should PTPN7 Antibody (Ab349232) be stored to maintain activity?

PTPN7 Antibody should be stored at -20°C. It is strongly recommended to prepare single-use aliquots upon receipt to avoid repeated freeze-thaw cycles, which can significantly reduce antibody performance. Refer to the product datasheet for specific formulation and storage buffer details.

What controls should I include when using PTPN7 Antibody?

Always include a no-primary-antibody negative control to assess background signal. For specificity confirmation, use PTPN7-knockout or siRNA knockdown cell lines as genetic negative controls, and include a PTPN7-positive cell lysate as a positive control. These controls are essential for data interpretation and publication.

How do I troubleshoot weak or absent signal when using PTPN7 Antibody in Western blot?

First, confirm that PTPN7 is expressed in your chosen cell or tissue model using published expression databases. Next, verify antibody dilution and incubation conditions match the datasheet recommendations. Ensure that lysis buffer contains appropriate protease and phosphatase inhibitors. If signal remains absent, check secondary antibody compatibility and the integrity of the transfer membrane.

References

1. Alonso A, Sasin J, Bottini N, et al. Protein tyrosine phosphatases in the human genome. Cell. 2004;117(6):699-711. doi:10.1016/j.cell.2004.05.018
2. Saxena M, Williams S, Taskén K, Mustelin T. Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase. Nat Cell Biol. 1999;1(5):305-311. doi:10.1038/13024
3. Aladdin Scientific. PTPN7 Antibody (Ab349232) Product Datasheet. Aladdin Scientific; accessed 2024.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.